Sebia, the world leader in capillary electrophoresis, today announces that Capillarys 3 Tera now has the CE mark for HbA1c and serum protein testing, and immunotyping. The CE mark for these tests is ...

Advances and innovations in laboratory technologies for performing protein electrophoresis and immunotyping, combined with the workforce shortage of laboratory professionals have prompted many ...

DUBLIN--(BUSINESS WIRE)--The "Sebia SA - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering. Summary Sebia SA (Sebia) is a medical device ...

Sebia, a market leader in protein electrophoresis and tests for the diagnosis of haemoglobin disorders, announces the debut of its Haemoglobins Atlas. This tool, which has been developed for the first ...

Hemoglobin A1c is used clinically as a biomarker for the diagnosis and management of diabetes mellitus. Various methods are available to measure HbA1c and each has advantages and limitations. The ...

LONDON--(BUSINESS WIRE)--The capillary electrophoresis market is poised to grow by USD 300.97 million during 2020-2024 progressing at a CAGR of almost 7% during the forecast period. The report on the ...